FDA Approves Opioid 1,000x Stronger Than Morphine

The FDA says that Dsuvia is necessary to provide pain relief to soldiers, but critics are wary of a drug that powerful.

Dsuvia Single Dose Packaging / Image: Dsuvia
Dsuvia Single Dose Packaging / Image: Dsuvia

A recent Popular Science article discussed a new ultra-powerful drug that just received FDA approval. Dsuvia, formulated by AcelRX Pharmaceuticals, is a new form of a drug called sufentanil, which is reportedly a 10-times more powerful version of fentanyl. It comes in a 30-microgram tablet that is taken under the tongue via a special applicator that dispenses a single dose.

According to FDA commissioner Scot Gottlieb, Dsuvia won’t be sold in retail pharmacies, and will only be administered in “medically-supervised health care settings.” He went on to say that the special single-dose applicator will help prevent accidental overdose. The FDA’s Anesthetic and Analgesic Drug Product Advisory Committee voted in favor of the drug in October, and the agency approved it on November 2nd. It should hit the market in early 2019.

FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report